PTGX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.45

Margin Of Safety %

Put/Call OI Ratio

1.68

EPS Next Q Diff

0.53

EPS Last/This Y

4.7

EPS This/Next Y

-3.49

Price

99.97

Target Price

116.69

Analyst Recom

1.23

Performance Q

19.16

Upside

-123.4%

Beta

1.88

Ticker: PTGX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	PTGX	97.55	0.41	0.33	7412
2026-04-14	PTGX	104.8	0.40	0.09	7385
2026-04-15	PTGX	105.39	0.44	0.30	7051
2026-04-20	PTGX	105.33	0.72	0.03	3140
2026-04-23	PTGX	102.63	0.70	0.19	3244
2026-04-24	PTGX	99.83	0.69	4.70	3269
2026-04-27	PTGX	98.33	0.72	35.87	3322
2026-04-28	PTGX	101.29	1.03	0.05	3951
2026-04-29	PTGX	98.57	1.48	0.38	4863
2026-04-30	PTGX	98.89	1.48	10.00	4872
2026-05-01	PTGX	98.22	1.48	0.00	4882
2026-05-04	PTGX	99.54	1.48	0.00	4880
2026-05-05	PTGX	99.16	1.48	0.00	4881
2026-05-06	PTGX	104.1	1.48	2.88	4885
2026-05-07	PTGX	98.8	1.47	0.50	4942
2026-05-08	PTGX	99.36	1.47	0.00	4950
2026-05-11	PTGX	103.58	1.48	26.73	4935
2026-05-12	PTGX	100.04	1.68	0.00	5322
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	PTGX	97.54	-244.3	-	2.77
2026-04-14	PTGX	104.69	-244.3	-	2.77
2026-04-15	PTGX	105.44	-244.3	-	2.77
2026-04-16	PTGX	103.78	-244.3	-	2.77
2026-04-17	PTGX	106.05	-244.3	-	2.77
2026-04-20	PTGX	105.43	-244.3	-	2.77
2026-04-21	PTGX	105.91	-244.3	-	2.77
2026-04-22	PTGX	105.56	-244.3	-	2.77
2026-04-23	PTGX	102.55	-244.3	-	2.77
2026-04-24	PTGX	100.00	-244.3	-	2.77
2026-04-27	PTGX	98.43	-244.3	-	2.77
2026-04-28	PTGX	101.12	-244.3	-	2.77
2026-04-30	PTGX	98.91	-244.3	-	2.77
2026-05-01	PTGX	98.28	-244.3	-	2.77
2026-05-04	PTGX	99.54	-244.3	-	2.77
2026-05-05	PTGX	99.19	-244.3	-	2.77
2026-05-06	PTGX	104.00	-244.3	-	2.77
2026-05-07	PTGX	98.85	-244.3	-	2.77
2026-05-08	PTGX	99.25	356.0	-	2.65
2026-05-11	PTGX	103.51	356.0	-	2.65
2026-05-12	PTGX	99.97	431.3	-	2.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	PTGX	-8.20	2.03	14.38
2026-04-14	PTGX	-8.20	2.03	14.38
2026-04-15	PTGX	-7.93	2.03	14.38
2026-04-16	PTGX	-7.93	2.03	14.38
2026-04-17	PTGX	-7.93	2.03	14.38
2026-04-20	PTGX	-7.93	2.06	14.38
2026-04-21	PTGX	-7.97	2.06	14.38
2026-04-22	PTGX	-7.97	2.06	14.38
2026-04-23	PTGX	-7.97	2.06	14.38
2026-04-24	PTGX	-7.97	2.06	14.38
2026-04-27	PTGX	-7.97	2.68	13.97
2026-04-28	PTGX	-8.22	2.68	13.97
2026-04-29	PTGX	-8.22	2.68	13.97
2026-04-30	PTGX	-8.22	2.68	13.97
2026-05-01	PTGX	-8.22	2.68	13.97
2026-05-04	PTGX	-8.22	2.51	13.97
2026-05-05	PTGX	-8.22	2.51	13.97
2026-05-06	PTGX	-8.22	2.51	13.97
2026-05-07	PTGX	-8.22	2.51	13.97
2026-05-08	PTGX	-8.17	2.51	13.86
2026-05-11	PTGX	-8.17	3.34	13.86
2026-05-12	PTGX	-9.49	3.34	12.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.05

Avg. EPS Est. Current Quarter

1.82

Avg. EPS Est. Next Quarter

0.58

Insider Transactions

-9.49

Institutional Transactions

3.34

Beta

1.88

Average Sales Estimate Current Quarter

186

Average Sales Estimate Next Quarter

172

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

7.3

Max Drawdown 5-Year %

-85.8

Target Price

116.69

P/E

Forward P/E

PEG

P/S

86.79

P/B

9.79

P/Free Cash Flow

EPS

-1.8

Average EPS Est. Cur. Y

2.65

EPS Next Y. (Est.)

-0.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-154.88

Relative Volume

0.86

Return on Equity vs Sector %

-44.4

Return on Equity vs Industry %

-28.8

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.13

EBIT Estimation

◆ PTGX Healthcare

$99.95

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

11/25

Volume

4/15

Valuation

6/20

TP/AR

5/10

Options

3/10

RSI

48.8

Range 1M

27%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

22/30

Estimates

4/20

Inst/Vol

7/15

Options

4/10

EPS Yr

291.1%

EPS NY

-128.2%

52W%

85.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +16.7% upside

Quality

6/30

Valuation

5/30

Growth

16/25

Stability

8/10

LT Trend

0/5

Upside

+16.7%

Quality

Protagonist Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 131

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

PTGX

Latest News

—

Caricamento notizie per PTGX…

stock quote shares PTGX – Protagonist Therapeutics Inc Stock Price stock today

news today PTGX – Protagonist Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PTGX – Protagonist Therapeutics Inc yahoo finance google finance

stock history PTGX – Protagonist Therapeutics Inc invest stock market

stock prices PTGX premarket after hours

ticker PTGX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PTGX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y